Opinion: The Backstory on High Drug Prices

While it’s no secret that drug prices in the U.S. have been escalating at an alarming rate, one of the more consistently-explored root causes seems to be the absence of competitive pricing on the part of CMS. In an article posted on The Florida Times-Union’s Jacksonville.com, retired finance professor Joseph B. Steinman provides some thought provoking comments on the issue. Read the article here…

 

Notice: The “Read more…” link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid  on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.